As part of MaRS Innovation’s strategy to bundle technologies, our first initiative focused on regenerative medicine and creating the Centre for Commercialization of Regenerative Medicine (CCRM) located in Toronto, Ontario.

We are pleased that these efforts have been recognized by the Government of Canada‘s National Centres of Excellence (NCE) program, which recently announced a $15 million funding grant for CCRM through the Centres of Excellence for Commercialization and Research.

Posted by Susanne Staer, executive assistant to the president & CEO.